Several studies have indicated a role of innate and adaptive immunity in HCC progression and control [2,3,5], e.g., a longer progression-free survival has been associated with increased frequencies of CD8+ T cells targeting tumor-associated antigens [6], and of natural killer cells (NK cells) [7,8]. This evidence concerns the gene CD8A and hepatocellular carcinoma.